JPMorgan Chase & Co’s Day One Biopharmaceuticals DAWN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $579K | Buy |
89,102
+27,566
| +45% | +$179K | ﹤0.01% | 3993 |
|
|
2025
Q1 | $488K | Buy |
61,536
+1,109
| +2% | +$8.79K | ﹤0.01% | 4033 |
|
|
2024
Q4 | $766K | Sell |
60,427
-556
| -0.9% | -$7.05K | ﹤0.01% | 3943 |
|
|
2024
Q3 | $849K | Buy |
60,983
+530
| +0.9% | +$7.38K | ﹤0.01% | 3736 |
|
|
2024
Q2 | $833K | Sell |
60,453
-10,756
| -15% | -$148K | ﹤0.01% | 3596 |
|
|
2024
Q1 | $1.18M | Sell |
71,209
-33,587
| -32% | -$555K | ﹤0.01% | 3468 |
|
|
2023
Q4 | $1.53M | Buy |
104,796
+13,270
| +14% | +$194K | ﹤0.01% | 3290 |
|
|
2023
Q3 | $1.12M | Buy |
91,526
+23,942
| +35% | +$294K | ﹤0.01% | 3336 |
|
|
2023
Q2 | $807K | Buy |
67,584
+45,373
| +204% | +$542K | ﹤0.01% | 3545 |
|
|
2023
Q1 | $297K | Sell |
22,211
-49,795
| -69% | -$666K | ﹤0.01% | 4100 |
|
|
2022
Q4 | $1.55M | Sell |
72,006
-5,308
| -7% | -$114K | ﹤0.01% | 3118 |
|
|
2022
Q3 | $1.55M | Buy |
77,314
+60,799
| +368% | +$1.22M | ﹤0.01% | 3083 |
|
|
2022
Q2 | $295K | Sell |
16,515
-4,436
| -21% | -$79.2K | ﹤0.01% | 4145 |
|
|
2022
Q1 | $208K | Sell |
20,951
-31,009
| -60% | -$308K | ﹤0.01% | 4425 |
|
|
2021
Q4 | $875K | Buy |
51,960
+47,737
| +1,130% | +$804K | ﹤0.01% | 3767 |
|
|
2021
Q3 | $100K | Buy |
4,223
+4,169
| +7,720% | +$98.7K | ﹤0.01% | 4711 |
|
|
2021
Q2 | $1K | Buy |
+54
| New | +$1K | ﹤0.01% | 5400 |
|